Identification and Characterization of a Novel Uropathogenic Escherichia coli -Associated Fimbrial Gene Cluster

ABSTRACT Recently, we identified a fimbrial usher gene in uropathogenic Escherichia coli strain CFT073 that is absent from an E. coli laboratory strain. Analysis of the CFT073 genome indicates that this fimbrial usher gene is part of a novel fimbrial gene cluster, aufABCDEFG. Analysis of a collection of pathogenic and commensal strains of E. coli and related species revealed that the auf gene cluster was significantly associated with uropathogenic E. coli isolates. For in vitro expression analysis of the auf gene cluster, RNA was isolated from CFT073 bacteria grown to the exponential or stationary phase in Luria-Bertani broth and reverse transcriptase PCR (RT-PCR) with oligonucleotide primers specific to the major subunit, aufA, was performed. We found that aufA is expressed in CFT073 only during the exponential growth phase; however, no expression of AufA protein was observed by Western blotting, indicating that under these conditions, the expression of the auf gene cluster is low. To determine if the auf gene cluster is expressed in vivo, RT-PCR was performed on bacteria from urine samples of mice infected with CFT073. Out of three independent experiments, we were able to detect expression of aufA at least once at 4, 24, and 48 h of infection, indicating that the auf gene cluster is expressed in the murine urinary tract. Furthermore, antisera from mice infected with CFT073 reacted with recombinant AufA in an enzyme-linked immunosorbent assay. To identify the structure encoded by the auf gene cluster, a recombinant plasmid containing the auf gene cluster under the T7 promoter was introduced into the E. coli BL-21 (AI) strain. Immunogold labeling using AufA antiserum revealed the presence of amorphous material extending from the surface of BL-21 cells. No hemagglutination or cellular adherence properties were detected in association with expression of AufA. Deletion of the entire auf gene cluster had no effect on the ability of CFT073 to colonize the kidney, bladder, or urine of mice. In addition, no significant histological differences between the parent and aufC mutant strain were observed. Therefore, Auf is a uropathogenic E. coli-associated structure that plays an uncertain role in the pathogenesis of urinary tract infections.

[1]  Stefan D Knight,et al.  Structure and Biogenesis of the Capsular F1 Antigen from Yersinia pestis Preserved Folding Energy Drives Fiber Formation , 2003, Cell.

[2]  F. Blattner,et al.  Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[3]  W. Donovan,et al.  Role of Type 1 Fimbria- and P Fimbria-Specific Adherence in Colonization of the Neurogenic Human Bladder by Escherichia coli , 2002, Infection and Immunity.

[4]  C. Tang,et al.  Type 1 fimbriae and extracellular polysaccharides are preeminent uropathogenic Escherichia coli virulence determinants in the murine urinary tract , 2002, Molecular microbiology.

[5]  Harry L. T. Mobley,et al.  Sat, the Secreted Autotransporter Toxin of Uropathogenic Escherichia coli, Is a Vacuolating Cytotoxin for Bladder and Kidney Epithelial Cells , 2002, Infection and Immunity.

[6]  J. Hacker,et al.  Loss of Regulatory Protein RfaH Attenuates Virulence of Uropathogenic Escherichia coli , 2002, Infection and Immunity.

[7]  I. Blomfield,et al.  Assessment of Virulence of Uropathogenic Escherichia coli Type 1 Fimbrial Mutants in Which the Invertible Element Is Phase-Locked On or Off , 2002, Infection and Immunity.

[8]  R. Rosqvist,et al.  Role of Fraction 1 Antigen of Yersinia pestis in Inhibition of Phagocytosis , 2002, Infection and Immunity.

[9]  P. Manning,et al.  Identification and Characterization of Assembly Proteins of CS5 Pili from Enterotoxigenic Escherichia coli , 2002, Journal of bacteriology.

[10]  J. Nataro,et al.  CHAPTER 6 – Enteroaggregative and Diffusely Adherent Escherichia Coli , 2002 .

[11]  F. Bahrani-Mougeot.  CHAPTER 8 – Uropathogenic Escherichia coli , 2002 .

[12]  M. Donnenberg.  Escherichia coli : virulence mechanisms of a versatile pathogen , 2002 .

[13]  A. Torres,et al.  TonB-Dependent Systems of Uropathogenic Escherichia coli: Aerobactin and Heme Transport and TonB Are Required for Virulence in the Mouse , 2001, Infection and Immunity.

[14]  T. Nicholson,et al.  Role of fimbriae as antigens and intestinal colonization factors of Salmonella serovars. , 2001, FEMS microbiology letters.

[15]  R. Conran,et al.  Mutation of the Gene Encoding Cytotoxic Necrotizing Factor Type 1 (cnf1) Attenuates the Virulence of Uropathogenic Escherichia coli , 2001, Infection and Immunity.

[16]  H. Mobley,et al.  In Vivo Dynamics of Type 1 Fimbria Regulation in UropathogenicEscherichia coli during Experimental Urinary Tract Infection , 2001, Infection and Immunity.

[17]  T. Silhavy,et al.  Cpx signaling pathway monitors biogenesis and affects assembly and expression of P pili , 2001, The EMBO journal.

[18]  Identification of putative urovirulence genes by subtractive cloning. , 2001, The Journal of infectious diseases.

[19]  Frederick R. Blattner,et al.  High-Density Microarray-Mediated Gene Expression Profiling of Escherichia coli , 2001, Journal of bacteriology.

[20]  C. Svanborg,et al.  P fimbriae enhance the early establishment of Escherichia coli in the human urinary tract , 2000, Molecular microbiology.

[21]  J. Sobel,et al.  Urinary tract infection: self-reported incidence and associated costs. , 2000, Annals of epidemiology.

[22]  B. Wanner,et al.  One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[23]  B. Foxman,et al.  Molecular Epidemiologic Approaches to Urinary Tract Infection Gene Discovery in Uropathogenic Escherichia coli , 2000, Infection and Immunity.

[24]  B. P. McNamara,et al.  A Large Toxin from Pathogenic Escherichia coli Strains That Inhibits Lymphocyte Activation , 2000, Infection and Immunity.

[25]  C. Struve,et al.  In vivo detection of Escherichia coli type 1 fimbrial expression and phase variation during experimental urinary tract infection. , 1999, Microbiology.

[26]  I. Henderson,et al.  Phylogenetic Analysis of Enteroaggregative and Diffusely Adherent Escherichia coli , 1999, Infection and Immunity.

[27]  R. Darouiche,et al.  Virulence Properties of Escherichia coli83972, a Prototype Strain Associated with Asymptomatic Bacteriuria , 1999, Infection and Immunity.

[28]  H. Mobley,et al.  In vivo phase variation of Escherichia coli type 1 fimbrial genes in women with urinary tract infection. , 1999, Infection and immunity.

[29]  R. Russell,et al.  Comparison of Escherichia coli strains recovered from human cystitis and pyelonephritis infections in transurethrally challenged mice. , 1999, Infection and immunity.

[30]  F. Blattner,et al.  Versatile insertion plasmids for targeted genome manipulations in bacteria: isolation, deletion, and rescue of the pathogenicity island LEE of the Escherichia coli O157:H7 genome , 1997, Journal of bacteriology.

[31]  C. Svanborg,et al.  Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[32]  J. Pinkner,et al.  Molecular basis of two subfamilies of immunoglobulin‐like chaperones. , 1996, The EMBO journal.

[33]  D. Schifferli,et al.  Identification of major and minor chaperone proteins involved in the export of 987P fimbriae , 1996, Journal of bacteriology.

[34]  H. Mobley,et al.  Urinary tract infections : molecular pathogenesis and clinical management , 1996 .

[35]  J. Shea,et al.  Simultaneous identification of bacterial virulence genes by negative selection. , 1995, Science.

[36]  S. Normark,et al.  The Gal(alpha 1-4)Gal-specific tip adhesin of Escherichia coli P-fimbriae is needed for pyelonephritis to occur in the normal urinary tract. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[37]  A. Khan,et al.  A minor 987P protein different from the structural fimbrial subunit is the adhesin , 1994, Infection and immunity.

[38]  K. Jarvis,et al.  Isogenic P‐fimbrial deletion mutants of pyelonephritogenic Escherichia coli: the role of α Gal(1–4)β Gal binding in virulence of a wild‐type strain , 1993 .

[39]  G. Cornelis,et al.  The Myf fibrillae of Yersinia enterocolitica , 1993, Molecular microbiology.

[40]  P W Russell,et al.  Rapid, synchronous, and stable induction of type 1 piliation in Escherichia coli by using a chromosomal lacUV5 promoter , 1993, Journal of bacteriology.

[41]  C. Svanborg,et al.  Persistence of Escherichia coli bacteriuria is not determined by bacterial adherence , 1991, Infection and immunity.

[42]  S. Moseley,et al.  Urovirulence determinants in Escherichia coli isolates causing first-episode and recurrent cystitis in women. , 1991, The Journal of infectious diseases.

[43]  H. Mobley,et al.  Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains , 1990, Infection and immunity.

[44]  J. Mekalanos,et al.  A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR , 1988, Journal of bacteriology.

[45]  J. Abraham,et al.  An invertible element of DNA controls phase variation of type 1 fimbriae of Escherichia coli. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[46]  M. Breimer,et al.  Specificity of binding of a strain of uropathogenic Escherichia coli to Gal alpha 1----4Gal-containing glycosphingolipids. , 1985, The Journal of biological chemistry.

[47]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[48]  U. Lindberg,et al.  Asymptomatic bacteriuria in schoolgirls. VIII. Clinical course during a 3-year follow-up. , 1978, The Journal of pediatrics.